Article Details
Retrieved on: 2024-10-21 14:19:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The FDA's approval marks a significant step for Boston Scientific in the treatment of paroxysmal atrial fibrillation, a common heart rhythm disorder.
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here